Replimune Group (REPL) Stock Price, Quote, News & History | Benzinga

SPY774.23 QQQ753.01 BTC/USD82,447.47−0.99%DIA507.85 GLD377.26 TLT76.90−0.32%

Replimune Group Inc (REPL) Stock Price, Quote, News & History

REPLNASDAQ

Trade with Public

Trade with Public

$13.20

-0.05-0.38%

Last update: Oct 8, 8:29 AM

$13.10

-0.15-1.13%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

-

Close

$13.20

Volume / Avg.

1.84K / 4.19M

Day Range

- - -

52 Wk Range

1.50 - 16.33

Market Cap

$1.23B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

39.42%

Days to Cover

11.14

Recent Replimune Group, Inc. News

Two Rejections, Messy Process: Replimune Finally Secures FDA Approval for Skin Cancer Treatment

FDA grants Replimune accelerated approval for TUDRIQEV in combination with nivolumab to treat advanced cutaneous melanoma.

Vandana Singh

This Palantir Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Analysts upgraded Replimune, Madrigal, BBB Foods, Palantir, and Fomento Economico. See other opinions and price targets for these stocks.

Avi Kapoor

Replimune Skin Cancer Therapy Hopes Revive After Positive FDA Panel Vote

FDA advisory panel backed Replimune's RP1 melanoma data ahead of the agency's August 2 decision despite earlier staff criticism.

Vandana Singh

Nasdaq Surges 300 Points; Amazon Shares Jump Following Upbeat Earnings

US stocks rise, Nasdaq up 300 points. Dow up 0.36%, Nasdaq up 1.31%, S&P 500 up 0.65%. Amazon shares jump 14% after posting strong Q2 results.

Avi Kapoor

This Plexus Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday

Top Wall Street analysts upgraded IP, AXTI, REPL, and PLXS stocks with higher price targets. See what other analysts think about these stocks.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-279.06M

Investing Cash Flow (TTM)

295.79M

Financing Cash Flow (TTM)

67.25M

Free Cash Flow (TTM)

-280.55M

Capital Expenditure (TTM)

-1.49M

Net Change in Cash (TTM)

83.98M

Analyst Trends and Forecast

3

2

Apr

1

May

1

2

Jun

1

1

Jul

4

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.16B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

11.78

Earnings Yield % (TTM)

-23.85%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.12

Company Debt

Total Debt

$84.11M

LT Debt

$84.11M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$773.00K

Total Cash

$185.36M

Debt to Equity

1.06

Issuance of Debt (TTM)

$34.23M

Repayment of Debt (TTM)

-$773.00K